Intellectual Disability
|
0.430 |
Biomarker
|
group |
HPO |
|
|
|
Schizophrenia
|
0.330 |
Biomarker
|
disease |
BEFREE |
In addition to novel GWS loci, we have identified a significant genetic correlation with schizophrenia and association of ASD with several neurodevelopmental-related genes such as <i>EXT1</i>, <i>ASTN2</i>, <i>MACROD2</i>, and <i>HDAC4.</i>
|
28540026 |
2017 |
Malignant neoplasm of breast
|
0.330 |
Biomarker
|
disease |
BEFREE |
Together these results demonstrate that serum miR-125a-5p level in breast cancer may be a useful prognostic biomarker and offer a novel therapeutic avenue by targeting HDAC4 in breast cancer.
|
25504437 |
2015 |
Malignant neoplasm of breast
|
0.330 |
Biomarker
|
disease |
BEFREE |
We propose miR-10b-HDAC4 nexus as one of the molecular mechanism of tamoxifen resistance which can potentially be expolited as a novel targeted therapeutic approach for the clinical management of tamoxifen-resistant breast cancers.
|
26206152 |
2015 |
Malignant neoplasm of breast
|
0.330 |
Biomarker
|
disease |
BEFREE |
Using breast cancer and glioblastoma as examples to examine intrinsic subtypes of particular cancers, EZH2 activation was highest in luminal breast cancers and proneural glioblastomas, while HDAC4 activation was highest in basal breast cancer and mesenchymal glioblastoma.
|
24079712 |
2013 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
BEFREE |
The results suggest that HDAC3 and HDAC4 genes might play a role in the pathophysiology of schizophrenia in a Korean population.
|
20471694 |
2010 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
PSYGENET |
The results suggest that HDAC3 and HDAC4 genes might play a role in the pathophysiology of schizophrenia in a Korean population.
|
20471694 |
2010 |
Schizophrenia
|
0.330 |
AlteredExpression
|
disease |
BEFREE |
The mRNA expression level of an epigenetically regulated schizophrenia candidate gene GAD67 was strongly and negatively correlated with the mRNA expression levels of HDAC1, HDAC3 and HDAC4 levels.
|
17961987 |
2008 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
PSYGENET |
The mRNA expression level of an epigenetically regulated schizophrenia candidate gene GAD67 was strongly and negatively correlated with the mRNA expression levels of HDAC1, HDAC3 and HDAC4 levels.
|
17961987 |
2008 |
Malignant neoplasm of breast
|
0.330 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Malignant neoplasm of urinary bladder
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
We also observed increased expression in Hdac4, -7, and -9 in commonly used BC mouse models.
|
31137849 |
2019 |
Bladder Neoplasm
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
We also observed increased expression in Hdac4, -7, and -9 in commonly used BC mouse models.
|
31137849 |
2019 |
Malignant neoplasm of urinary bladder
|
0.320 |
Biomarker
|
disease |
BEFREE |
The results of our immunohistochemistry (IHC) staining studies further revealed a strong correlation between the over-expression of HDAC4 and increased bladder cancer occurrence (p < 0.001) as well as a marginal significance of increasing incidence of HDAC4 positivity seen with an increase in severity of bladder cancer (p = 0.08).
|
21507255 |
2011 |
Malignant neoplasm of urinary bladder
|
0.320 |
Biomarker
|
disease |
CTD_human |
The results of our immunohistochemistry (IHC) staining studies further revealed a strong correlation between the over-expression of HDAC4 and increased bladder cancer occurrence (p < 0.001) as well as a marginal significance of increasing incidence of HDAC4 positivity seen with an increase in severity of bladder cancer (p = 0.08).
|
21507255 |
2011 |
Bladder Neoplasm
|
0.320 |
Biomarker
|
disease |
CTD_human |
The results of our immunohistochemistry (IHC) staining studies further revealed a strong correlation between the over-expression of HDAC4 and increased bladder cancer occurrence (p < 0.001) as well as a marginal significance of increasing incidence of HDAC4 positivity seen with an increase in severity of bladder cancer (p = 0.08).
|
21507255 |
2011 |
Bladder Neoplasm
|
0.320 |
Biomarker
|
disease |
BEFREE |
The results of our immunohistochemistry (IHC) staining studies further revealed a strong correlation between the over-expression of HDAC4 and increased bladder cancer occurrence (p < 0.001) as well as a marginal significance of increasing incidence of HDAC4 positivity seen with an increase in severity of bladder cancer (p = 0.08).
|
21507255 |
2011 |
Mental Depression
|
0.310 |
Biomarker
|
disease |
PSYGENET |
In BPD, the expression of HDAC4 mRNA was increased only in a depressive state, and the expression of HDAC6 and -8 was decreased in both depressive and remissive states compared to controls, whereas the first-degree relatives did not show any significant alteration in expression levels.
|
19767015 |
2010 |
Mental Depression
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
In BPD, the expression of HDAC4 mRNA was increased only in a depressive state, and the expression of HDAC6 and -8 was decreased in both depressive and remissive states compared to controls, whereas the first-degree relatives did not show any significant alteration in expression levels.
|
19767015 |
2010 |
Contact Dermatitis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay.
|
25724174 |
2015 |
Contact hypersensitivity
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay.
|
25724174 |
2015 |
Malignant mesothelioma
|
0.300 |
Biomarker
|
disease |
CTD_human |
MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.
|
25756049 |
2015 |
BRACHYDACTYLY, TYPE E1
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Presented here are three individuals with haploinsufficiency of HDAC4 who have brachydactyly type E, non-dysmorphic facial features, and normal intelligence.
|
24715439 |
2014 |
Familial primary pulmonary hypertension
|
0.300 |
Biomarker
|
disease |
CTD_human |
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
|
22711276 |
2012 |
PULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED
|
0.300 |
Biomarker
|
disease |
CTD_human |
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
|
22711276 |
2012 |
Pulmonary Hypertension, Primary, Fenfluramine-Associated
|
0.300 |
Biomarker
|
disease |
CTD_human |
Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid.
|
22711276 |
2012 |